Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Market Insights
- Regulatory Landscape
- Patent Review
- Product Recalls
- Product Pipeline
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Drivers
- Wide Range of Potential Applications of Combinations Products
- Growing Prevalence of Chronic Diseases
- Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
- Restraints
- Device Reliability and Robustness
- Human Factors Testing
- Drug and Device Integration
- Accommodating Different Volumes
- Challenges
- Biological Safety Challenges in Drug-Device Combinations
- Regulatory Challenges
- Opportunities
- Technology advancements and Innovative Product Launches
- Continuous Growth
- Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market
Chapter 4 Market Segmentation Analysis
- Segmentation Breakdown
- Drug-Device Combinations Market by Product Type
- Drug/Biologic-Device Combination Products
- Drug-Biologic Drug-Device Combination Products
- Drug, Device and Biologic Combination Products
- Drug-Device Combinations Market by Application
- Cardiovascular Diseases
- Metabolic Disorders
- Respiratory Diseases
- Wound Care
- Oncology
- Orthopedic Conditions
- Others
- Geographic Breakdown
- Drug-Device Combinations Market, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 5 Emerging Trends and Technologies
- Overview
- AI in Drug-Device Combination
- Nanotechnology
- Computational Models and Simulation
- Human Organs-on-Chips: Revolutionizing Medical Research
- Implantable Drug Delivery Systems
- Wireless Implants
- Smart Drug Delivery Devices for 3D Printing
- Recent Approvals and Launch of Novel Drug-device Combination Products
Chapter 6 ESG Development
- Introduction
- ESG Sustainability in Drug-Device Combinations Market
- ESG Risk Ratings
- WHO Guidelines and Global Initiatives
- Publisher Viewpoint
Chapter 7 Competitive Landscape
- Company Share Analysis
- Mergers, Acquisitions and Collaborations
- Strategic Alliances
List of Tables
Summary Table: Global Market for Drug-Device Combinations, by Product Type, Through 2029
Table 1: EU Combination Product Regulation
Table 2: Granted Patents on Drug-Device Combination Products in 2024, U.S.
Table 3: Recalled Drug-Device Combination Products, 2021-2024
Table 4: Drug-Device Combination Product Pipeline
Table 5: Projected Number of Adults 50 Years and Older With =1 Chronic Condition in the United States, 2020-2050
Table 6: Global Market for Drug-Device Combination Products, by Product Type, Through 2029
Table 7: Global Market for Drug/Biologic-Device Combination Products, by Product Type, Through 2029
Table 8: Global Market for Drug Eluting Stents (DES), by Region, Through 2029
Table 9: Marketed or Late-stage Development Products in DCDs
Table 10: Global Market for Prefilled Syringe (PFS), by Region, Through 2029
Table 11: Global Market for Inhalers, by Region, Through 2029
Table 12: Global Market for Nebulizers, by Region, Through 2029
Table 13: Global Market for Wound Care Products, by Region, Through 2029
Table 14: Global Market for Implants, by Region, Through 2029
Table 15: Available Catheter Types in Clinical Use, 2022
Table 16: Global Market for Antimicrobial Catheters, by Region, Through 2029
Table 17: Global Market for Transdermal Patches, by Region, Through 2029
Table 18: Global Market for Photodynamic Therapy (PDT), by Region, Through 2029
Table 19: Global Market for Other Types of Drug-Device Combination Products, by Region, Through 2029
Table 20: Global Market for Drug-Biologic Combination Products, by Product Type, Through 2029
Table 21: FDA Approved ADCs
Table 22: Global Market for Antibody Drug Conjugates (ADC), by Region, Through 2029
Table 23: Global Market for Monoclonal Antibodies (mAbs), by Region, Through 2029
Table 24: Global Market for Other Types of Drug-Biologic Combination Products, by Region, Through 2029
Table 25: Global Market for Drug-Device Combination Products, by Application, Through 2029
Table 26: Global Market for Drug-Device Combination Products for Cardiovascular Diseases, by Region, Through 2029
Table 27: Global Market for Drug-Device Combination Products for Metabolic Disorders, by Region, Through 2029
Table 28: Global Market for Drug-Device Combination Products for Respiratory Diseases, by Region, Through 2029
Table 29: Global Market for Drug-Device Combination Products for Wound Care, by Region, Through 2029
Table 30: Global Market for Drug-Device Combination Products in Oncology, by Region, Through 2029
Table 31: Global Market for Drug-Device Combination Products for Orthopedic Conditions, by Region, Through 2029
Table 32: Global Market for Drug-Device Combination Products for Other Chronic Diseases, by Region, Through 2029
Table 33: Global Market for Drug-Device Combination Products, by Region, Through 2029
Table 34: North American Market for Drug-Device Combination Products, by Country, Through 2029
Table 35: European Market for Drug-Device Combination Products, by Country, Through 2029
Table 36: Asia-Pacific Market for Drug-Device Combination Products, by Country, Through 2029
Table 37: ESG Highlights, by Major Players, 2023
Table 38: ESG Rankings for Major Drug-Device Combinations Manufacturing Companies, 2023
Table 39: Market Players and the Products They Offer for Various Applications
Table 40: Mergers and Acquisitions: Drug-Device Combination Products Manufacturers, 2021-2024
Table 41: Major Strategic Alliances in the Drug-Device Combination Industry, 2021-2024
Table 42: Information Sources in this Report
Table 43: Major Abbreviations Used in This Report
Table 44: 3M: Company Snapshot
Table 45: 3M: Financial Performance, FY 2022 and 2023
Table 46: 3M: Products Portfolio
Table 47: 3M: News/Key Developments, 2023
Table 48: Abbott: Company Snapshot
Table 49: Abbott: Financial Performance, FY 2022 and 2023
Table 50: Abbott: Products Portfolio
Table 51: Abbott: News/Key Developments, 2024
Table 52: B Braun SE: Company Snapshot
Table 53: B Braun SE: Financial Performance, FY 2022 and 2023
Table 54: B. Braun SE: Products Portfolio
Table 55: B. Braun SE: News/Key Developments, 2022
Table 56: BD: Company Snapshot
Table 57: BD: Financial Performance, FY 2022 and 2023
Table 58: BD: Product Portfolio
Table 59: BD: News/Key Developments, 2023
Table 60: Boston Scientific Corp.: Company Snapshot
Table 61: Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 62: Boston Scientific Corp.: Products Portfolio
Table 63: Boston Scientific Corp.: News/Key Developments, 2024
Table 64: Johnson & Johnson Services Inc.: Company Snapshot
Table 65: Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 66: Johnson & Johnson Services Inc.: Product Portfolio
Table 67: Johnson & Johnson Services Inc.: News/Key Developments, 2022
Table 68: Medtronic: Company Snapshot
Table 69: Medtronic: Financial Performance, FY 2022 and 2023
Table 70: Medtronic: Products Portfolio
Table 71: Medtronic: News/Key Developments, 2024
Table 72: Smith+Nephew: Company Snapshot
Table 73: Smith+Nephew: Financial Performance, FY 2022 and 2023
Table 74: Smith+Nephew: Products Portfolio
Table 75: Smith+Nephew: News/Key Developments, 2024
Table 76: Stryker: Company Snapshot
Table 77: Stryker: Financial Performance, FY 2022 and 2023
Table 78: Stryker: Products Portfolio
Table 79: Terumo Corp.: Company Snapshot
Table 80: Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 81: Terumo Corp.: Product Portfolio
Table 82: Terumo Corp.: News/Key Developments, 2023
List of Figures
Summary Figure: Global Market for Drug-Device Combinations, by Product Type, 2021-2029
Figure 1: U.S. FDA Combination Product Approval Pathway
Figure 2: Snapshot of the Global Markets for Drug-Device Combinations
Figure 3: Share of New Cancer Cases (Incidence) Globally, by Region, 2022
Figure 4: Share of Cancer Mortality Cases Globally, by Region, 2022
Figure 5: Global Market Shares of Drug-Device Combination Products, by Product Type, 2023
Figure 6: Global Market for Drug-Device Combination Products, by Region, 2021-2029
Figure 7: Global Market Shares of Drug-Device Combination Products, by Region, 2023
Figure 8: Traditional and New Generation Drug-Device Combination
Figure 9: Global Market Shares of Drug-Device Combination Products, by Company, 2023
Figure 10: 3M: Revenue Share, by Country/Region, FY 2023
Figure 11: 3M: Revenue Share, by Business Unit, FY 2023
Figure 12: Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13: Abbott: Revenue Share, by Business Unit, FY 2023
Figure 14: B Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 15: B Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 16: BD: Revenue Share, by Country/Region, FY 2023
Figure 17: BD: Revenue Share, by Business Unit, FY 2023
Figure 18: Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 19: Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 20: Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21: Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 22: Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 23: Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 24: Smith+Nephew: Revenue Share, by Country/Region, FY 2023
Figure 25: Smith+Nephew: Revenue Share, by Business Unit, FY 2023
Figure 26: Stryker: Revenue Share, by Country/Region, FY 2023
Figure 27: Stryker: Revenue Share, by Business Unit, FY 2023
Figure 28: Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29: Terumo Corp.: Revenue Share, by Business Unit, FY 2023
